Advisory Committees; Tentative Schedule of Meetings for 2010, 69119-69122 [E9-30973]

Download as PDF Federal Register / Vol. 74, No. 249 / Wednesday, December 30, 2009 / Notices mstockstill on DSKH9S0YB1PROD with NOTICES amended (5 U.S.C. Appendix 2) notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The purpose of this meeting is to evaluate requests for preclinical development resources for potential new therapeutics for the treatment of cancer. The outcome of the evaluation will provide information to internal NCI committees that will decide whether NCI should support requests and make available contract resources for development of the potential therapeutic to improve the treatment of various forms of cancer. The research proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material and personal information concerning individuals associated with the proposed research projects, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Special Emphasis Panel, NCI Experimental Therapeutics Program (NExT) Cycle 2. Date: January 13, 2010. Time: 8:30 a.m.–4:30 p.m. Agenda: To evaluate the NCI Experimental Therapeutics Program Portfolio. Place: National Institutes of Health, Building 31A—Conference Room 8A28, 31 Center Drive, Bethesda, MD 20817. Contact Person: Dr. Barbara Mroczkowski, Executive Secretary, NCI Experimental Therapeutics Program, National Cancer Institute, NIH, 31 Center Drive, Room 3A44, Bethesda, MD 20892. (301) 496–4291. mroczkowskib@mail.nih.gov. This notice is being published less than 30 days prior to the meeting due to scheduling conflicts. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: December 22, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–31012 Filed 12–29–09; 8:45 am] BILLING CODE 4140–01–P VerDate Nov<24>2008 19:01 Dec 29, 2009 Jkt 220001 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Special Emphasis Panel, NCI Discovery and Development P01. Date: February 2–3, 2010. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 20814. Contact Person: Sergei Radaev, PhD., Scientific Review Officer, Resources And Training Review Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Blvd., Room 8113, Rockville, MD 20852, 301–435–5655, sradaev@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel, Epidemiology, Prevention, Control & Population Sciences. Date: February 9–11, 2010. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda North Marriott Hotel & Conference Center, Montgomery County Conference Center Facility, 5701 Marinelli Road, North Bethesda, MD 20852. Contact Person: Wlodek Lopaczynski, M.D., PhD, Scientific Review Officer, Research Programs Review Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Blvd., Room 8131, Bethesda, MD 20892, 301–594–1402, lopacw@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel, Molecular Oncology—Basic, Translational, and Clinical Studies. Date: February 9–11, 2010. Time: 5 p.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda North Marriott Hotel & Conference Center, 5701 Marinelli Road, Bethesda, MD. Contact Person: David G. Ransom, PhD, Scientific Review Officer, Research Programs PO 00000 Frm 00059 Fmt 4703 Sfmt 4703 69119 Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Blvd., Rm. 8133, Bethesda, MD 20892–8328, 301–451–4757, david.ransom@nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel, SPORE in Gynecologic, Breast, and Skin Cancers. Date: February 17–19, 2010. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, Bethesda, MD. Contact Person: Caron A. Lyman, PhD, Scientific Review Officer, Research Programs Review Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Blvd, Room 8119, Bethesda, MD 20892–8328, 301–451–4761, lymanc@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel, SPORE in Brain, Leukemia, Myeloma, Sarcoma, Esophageal, GI, HN, and Pancreatic Cancers. Date: February 17–19, 2010. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Shamala K. Srinivas, PhD., Scientific Review Officer, Research Programs Review Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Boulevard, Room 8123, Bethesda, MD 20892, 301–594–1224, ss537t@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: December 21, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–30923 Filed 12–29–09; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2009–N–0664] Advisory Committees; Tentative Schedule of Meetings for 2010 AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) is announcing a tentative schedule of forthcoming meetings of its public advisory E:\FR\FM\30DEN1.SGM 30DEN1 69120 Federal Register / Vol. 74, No. 249 / Wednesday, December 30, 2009 / Notices committees for 2010. During 1991, at the request of the Commissioner of Food and Drugs (the Commissioner), the Institute of Medicine (the IOM) conducted a study of the use of FDA’s advisory committees. In its final report, one of the IOM’s recommendations was for the agency to publish an annual tentative schedule of its meetings in the Federal Register. This publication implements the IOM’s recommendation. FOR FURTHER INFORMATION CONTACT: Teresa L. Hays, Advisory Committee Oversight and Management Staff (HF– 4), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301–827–1220. SUPPLEMENTARY INFORMATION: The IOM, at the request of the Commissioner, undertook a study of the use of the FDA’s advisory committees. In its final report in 1992, one of the IOM’s recommendations was for FDA to adopt a policy of publishing an advance yearly schedule of its upcoming public advisory committee meetings in the Federal Register; FDA has implemented this recommendation. The annual publication of tentatively scheduled advisory committee meetings will provide both advisory committee members and the public with the opportunity, in advance, to schedule attendance at FDA’s upcoming advisory committee meetings. Because the schedule is tentative amendments to this notice will not be published in the Federal Register. However, changes to Committee Name the schedule will be posted on the FDA advisory committees’ Internet site located at https://www.fda.gov/Advisory Committees/default.htm. FDA will continue to publish a Federal Register notice 15 days in advance of each upcoming advisory committee meeting, to announce the meeting (21 CFR 14.20). The following list announces FDA’s tentatively scheduled advisory committee meetings for 2010. You may also obtain up-to-date information by calling the Advisory Committee Information Line, 1–800–741–8138 (301–443–0572 in the Washington, DC area) and use the appropriate Information Line Code for the committee in which you are interested. Tentative Date of Meeting(s) Advisory Committee 10-Digit Information Line Code OFFICE OF THE COMMISSIONER Pediatric Advisory Committee March 22, June 21–22, September 20–21, December 6–7 8732310001 Risk Communication Advisory Committee February 25–26, May 6–7, August 19–20, November 8–9 8732112560 Science Board to the Food and Drug Administration February 22, May 17, August 16, November 15 3014512603 Allergenic Products Advisory Committee April 30, October 26 3014512388 Blood Products Advisory Committee April 12–13, July 26–27, November 18–19 3014519516 Cellular, Tissue and Gene Therapies Advisory Committee To be announced 3014512389 Transmissible Spongiform Encephalopathies Advisory Committee To be announced 3014512392 Vaccines and Related Biological Products Advisory Committee February 22, May 19–20, September 15–16, November 17– 18 3014512391 Anesthetic and Life Support Drugs Advisory Committee January 28, April 22, April 23 3014512529 Anti Infective Drugs Advisory Committee August and October dates To be announced 3014512530 Antiviral Drugs Advisory Committee To be announced 3014512531 Arthritis Advisory Committee May dates To be announced 3014512532 Cardiovascular and Renal Drugs Advisory Committee January 11, March 1, April dates to be announced, July 28, July 29, December 8, December 9 3014512533 Dermatologic and Ophthalmic Drugs Advisory Committee To be announced 3014512534 Drug Safety and Risk Management Advisory Committee To be announced 3014512535 Endocrinologic and Metabolic Drugs Advisory Committee January 12, January 13, February 24, May 26–27 3014512536 Gastrointestinal Drugs Advisory Committee February 23, November dates to be announced 3014512538 Nonprescription Drugs Advisory Committee To be announced 3014512541 Oncologic Drugs Advisory Committee February 10, May 4, May 5, July 20, July 21, September 1, September 2, December 1, December 2 3014512542 CENTER FOR BIOLOGICS EVALUATION AND RESEARCH mstockstill on DSKH9S0YB1PROD with NOTICES CENTER FOR DRUG EVALUATION AND RESEARCH VerDate Nov<24>2008 19:01 Dec 29, 2009 Jkt 220001 PO 00000 Frm 00060 Fmt 4703 Sfmt 4703 E:\FR\FM\30DEN1.SGM 30DEN1 Federal Register / Vol. 74, No. 249 / Wednesday, December 30, 2009 / Notices Committee Name Tentative Date of Meeting(s) 69121 Advisory Committee 10-Digit Information Line Code Peripheral and Central Nervous System Drugs Advisory Committee March 23, March 24, June dates to be announced 3014512543 Pharmaceutical Science and Clinical Pharmacology, Advisory Committee March 17 3014512539 Psychopharmacologic Drugs Advisory Committee To be announced 3014512544 Pulmonary Allergy Drugs Advisory Committee March 9, March 10, April dates to be announced 3014512545 Reproductive Health Drugs, Advisory Committee May dates to be announced 3014512537 July 22, September 16 3014512398 CENTER FOR DEVICES AND RADIOLOGICAL HEALTH Device Good Manufacturing Practice Advisory Committee Medical Devices Advisory Committee (Comprised of 18 Panels) Anesthesiology and Respiratory Therapy Devices Panel April 30, June 23, September 15, November 10 3014512624 Circulatory System Devices Panel February 25, May 27, September 23, December 8–9 3014512625 Clinical Chemistry and Clinical Toxicology Devices Panel March 17–18, June 16–17, October 20–21 3014512514 Dental Products Panel March 23, April 13, May 11, July 13, September 14 3014512518 Ear, Nose, and Throat Devices Panel February 24, May 19, August 25, November 3–4 3014512522 Gastroenterology-Urology Devices Panel March 11–12, June 17–18, September 9–10, December 2–3 3014512523 General and Plastic Surgery Devices Panel February 4–5, May 20–21, August 12–13, November 4–5 3014512519 General Hospital and Personal Use Devices Panel March 5, July 28–29, November 17–18 3014512520 Hematology and Pathology Devices Panel January 21–22, April 22–23, July 8–9, October 21–22 3014512515 Immunology Devices Panel April 26, September 15, December 6 3014512516 Medical Devices Dispute Resolution Panel Meetings occur as needed 3014510232 Microbiology Devices Panel March 19, September 23 3014512517 Molecular and Clinical Genetics Panel April 15, October 5–6 3014510231 Neurological Devices Panel March 11–12, May 13–4, July 8–9, October 7–8, December 9–10 3014512513 Obstetrics and Gynecology Devices Panel April 22–23, July 15–16, October 21–22, December 16–17 3014512524 Ophthalmic Devices Panel February 25–26, April 22–23, June 24–25, October 28–29, November 18–19 3014512396 Orthopedic and Rehabilitation Devices Panel March 23, June 9–10, October 13–14, December 1–2 3014512521 Radiological Devices Panel April 28, July 21, September 15, November 17 3014512526 National Mammography Quality Assurance Advisory Committee January 25 3014512397 Technical Electronic Product Radiation Safety Standards Committee No meeting tentatively scheduled for 2010 3014512399 May 20–21 3014510564 March 18–19 3014512548 mstockstill on DSKH9S0YB1PROD with NOTICES CENTER FOR FOOD SAFETY AND APPLIED NUTRITION Food Advisory Committee CENTER FOR VETERINARY MEDICINE Veterinary Medicine Advisory Committee NATIONAL CENTER FOR TOXILOGICAL RESEARCH (NCTR) VerDate Nov<24>2008 19:01 Dec 29, 2009 Jkt 220001 PO 00000 Frm 00061 Fmt 4703 Sfmt 4703 E:\FR\FM\30DEN1.SGM 30DEN1 69122 Federal Register / Vol. 74, No. 249 / Wednesday, December 30, 2009 / Notices Committee Name Tentative Date of Meeting(s) Science Advisory Board to NCTR Advisory Committee 10-Digit Information Line Code November 17–18 3014512559 March, May, July, and November dates to be announced 8732110002 Center for Tobacco Tobacco Products Scientific Advisory Committee Dated: December 24, 2009. David Horowitz, Assistant Commissioner for Policy. [FR Doc. E9–30973 Filed 12–29–09; 8:45 am] BILLING CODE 4160–01–S DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2009–N–0664] Second Annual Sentinel Initiative Public Workshop AGENCY: Food and Drug Administration, HHS. mstockstill on DSKH9S0YB1PROD with NOTICES ACTION: Notice of public workshop. The Food and Drug Administration (FDA) is announcing the following workshop: Second Annual Sentinel Initiative Public Workshop. This 1-day workshop, organized and hosted by the Engelberg Center for Health Care Reform at Brookings, is supported by a grant from FDA. This workshop is intended to communicate the current status and future vision of active medical product surveillance activities and explore stakeholder perspectives on a broad range of issues. The workshop will feature a series of presentations on recently completed FDA contracts to inform various aspects of the development of the Sentinel System; an update on FDA’s ongoing pilot projects in active surveillance of medical product safety; and a discussion of three issues of broad interest: maintaining patient privacy while conducting medical product safety surveillance, developing the Sentinel System as a national resource for medical product safety surveillance for others outside of FDA, and developing a multi-purpose distributed system that can be used to conduct safety surveillance, comparative effectiveness research, product quality assessment and to address other types of public health questions. Date and Time: The workshop will be held on January 11, 2010, from 8:30 a.m. to 4:45 p.m. VerDate Nov<24>2008 19:01 Dec 29, 2009 Jkt 220001 Location: The workshop will be held at Marriott Metro Center at 775 12th Street NW., Washington, DC 20005. Contact: Kayla Garvin, Center for Drug Evaluation and Research, Bldg. 22, rm. 4339, Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD 20903, 301– 796–3755, e-mail: Kayla.Garvin@fda.hhs.gov. Registration: To attend the workshop, please register at https://tinyurl.com/ yce6c3z. When registering, provide the following information: Your name, title, company or organization (if applicable), address, phone number, and e-mail address. There is no fee to register for the public workshop and because seating is limited, registration will be on a first-come, first-served basis. A 1-hour lunch break is scheduled; however no food will be provided. There are multiple restaurants within walking distance of the hotel where attendees can purchase lunch. If you need special accommodations due to a disability, please contact Brookings’ event coordinator at 202–797–4391 or by email: sentinelevent@brookings.edu at least 7 days in advance. Transcripts: Please be advised that as soon as a transcript is available, it will be accessible at https://www.fda.gov/ Safety/FDAsSentinelInitiative/ ucm149341.htm. It may be viewed at the Division of Dockets Management (HFA– 305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD. A transcript will also be available in either hardcopy or on CD–ROM, after submission of a Freedom of Information request. Written requests are to be sent to the Division of Freedom of Information (HFI–35), Office of Management Programs, Food and Drug Administration, 5600 Fishers Lane, rm. 6–30, Rockville, MD 20857. Dated: December 23, 2009. David Horowitz, Assistant Commissioner for Policy. [FR Doc. E9–30971 Filed 12–29–09; 8:45 am] BILLING CODE 4160–01–S PO 00000 Frm 00062 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of meetings of the National Advisory Allergy and Infectious Diseases Council. The meetings will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications and/or contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Advisory Allergy and Infectious Diseases Council. Date: February 1, 2010. Open: 10:30 a.m. to 11:40 a.m. Agenda: Report from the Institute Director. Place: National Institutes of Health, Natcher Building, 45 Center Drive, Conference Rooms E1/E2, Bethesda, MD 20892. Closed: 11:40 a.m. to 12:40 p.m. Agenda: To review and evaluate grant applications and/or proposals. Place: National Institutes of Health, Natcher Building, 45 Center Drive, Conference Rooms E1/E2, Bethesda, MD 20892. Contact Person: Marvin R. Kalt, PhD, Director, Division of Extramural Activities, National Institutes of Health/NIAID, 6700B Rockledge Drive, MSC 7610, Bethesda, MD E:\FR\FM\30DEN1.SGM 30DEN1

Agencies

[Federal Register Volume 74, Number 249 (Wednesday, December 30, 2009)]
[Notices]
[Pages 69119-69122]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-30973]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2009-N-0664]


Advisory Committees; Tentative Schedule of Meetings for 2010

AGENCY:  Food and Drug Administration, HHS.

ACTION:  Notice.

-----------------------------------------------------------------------

SUMMARY:  The Food and Drug Administration (FDA) is announcing a 
tentative schedule of forthcoming meetings of its public advisory

[[Page 69120]]

committees for 2010. During 1991, at the request of the Commissioner of 
Food and Drugs (the Commissioner), the Institute of Medicine (the IOM) 
conducted a study of the use of FDA's advisory committees. In its final 
report, one of the IOM's recommendations was for the agency to publish 
an annual tentative schedule of its meetings in the Federal Register. 
This publication implements the IOM's recommendation.

FOR FURTHER INFORMATION CONTACT:  Teresa L. Hays, Advisory Committee 
Oversight and Management Staff (HF-4), Food and Drug Administration, 
5600 Fishers Lane, Rockville, MD 20857, 301-827-1220.

SUPPLEMENTARY INFORMATION: The IOM, at the request of the Commissioner, 
undertook a study of the use of the FDA's advisory committees. In its 
final report in 1992, one of the IOM's recommendations was for FDA to 
adopt a policy of publishing an advance yearly schedule of its upcoming 
public advisory committee meetings in the Federal Register; FDA has 
implemented this recommendation. The annual publication of tentatively 
scheduled advisory committee meetings will provide both advisory 
committee members and the public with the opportunity, in advance, to 
schedule attendance at FDA's upcoming advisory committee meetings. 
Because the schedule is tentative amendments to this notice will not be 
published in the Federal Register. However, changes to the schedule 
will be posted on the FDA advisory committees' Internet site located at 
https://www.fda.gov/AdvisoryCommittees/default.htm. FDA will continue to 
publish a Federal Register notice 15 days in advance of each upcoming 
advisory committee meeting, to announce the meeting (21 CFR 14.20).
    The following list announces FDA's tentatively scheduled advisory 
committee meetings for 2010. You may also obtain up-to-date information 
by calling the Advisory Committee Information Line, 1-800-741-8138 
(301-443-0572 in the Washington, DC area) and use the appropriate 
Information Line Code for the committee in which you are interested.

------------------------------------------------------------------------
                                                            Advisory
                                Tentative Date of        Committee 10-
      Committee Name                Meeting(s)         Digit Information
                                                           Line Code
------------------------------------------------------------------------
OFFICE OF THE COMMISSIONER
------------------------------------------------------------------------
  Pediatric Advisory        March 22, June 21-22,             8732310001
   Committee                 September 20-21,
                             December 6-7
------------------------------------------------------------------------
  Risk Communication        February 25-26, May 6-7,          8732112560
   Advisory Committee        August 19-20, November 8-
                             9
------------------------------------------------------------------------
  Science Board to the      February 22, May 17,              3014512603
   Food and Drug             August 16, November 15
   Administration
------------------------------------------------------------------------
CENTER FOR BIOLOGICS EVALUATION AND RESEARCH
------------------------------------------------------------------------
  Allergenic Products       April 30, October 26              3014512388
   Advisory Committee
------------------------------------------------------------------------
  Blood Products Advisory   April 12-13, July 26-27,          3014519516
   Committee                 November 18-19
------------------------------------------------------------------------
  Cellular, Tissue and      To be announced                   3014512389
   Gene Therapies Advisory
   Committee
------------------------------------------------------------------------
  Transmissible Spongiform  To be announced                   3014512392
   Encephalopathies
   Advisory Committee
------------------------------------------------------------------------
  Vaccines and Related      February 22, May 19-20,           3014512391
   Biological Products       September 15-16,
   Advisory Committee        November 17-18
------------------------------------------------------------------------
CENTER FOR DRUG EVALUATION AND RESEARCH
------------------------------------------------------------------------
  Anesthetic and Life       January 28, April 22,             3014512529
   Support Drugs Advisory    April 23
   Committee
------------------------------------------------------------------------
  Anti Infective Drugs      August and October dates          3014512530
   Advisory Committee        To be announced
------------------------------------------------------------------------
  Antiviral Drugs Advisory  To be announced                   3014512531
   Committee
------------------------------------------------------------------------
  Arthritis Advisory        May dates To be announced         3014512532
   Committee
------------------------------------------------------------------------
  Cardiovascular and Renal  January 11, March 1,              3014512533
   Drugs Advisory            April dates to be
   Committee                 announced, July 28, July
                             29, December 8, December
                             9
------------------------------------------------------------------------
  Dermatologic and          To be announced                   3014512534
   Ophthalmic Drugs
   Advisory Committee
------------------------------------------------------------------------
  Drug Safety and Risk      To be announced                   3014512535
   Management Advisory
   Committee
------------------------------------------------------------------------
  Endocrinologic and        January 12, January 13,           3014512536
   Metabolic Drugs           February 24, May 26-27
   Advisory Committee
------------------------------------------------------------------------
  Gastrointestinal Drugs    February 23, November             3014512538
   Advisory Committee        dates to be announced
------------------------------------------------------------------------
  Nonprescription Drugs     To be announced                   3014512541
   Advisory Committee
------------------------------------------------------------------------
  Oncologic Drugs Advisory  February 10, May 4, May           3014512542
   Committee                 5, July 20, July 21,
                             September 1, September
                             2, December 1, December
                             2
------------------------------------------------------------------------

[[Page 69121]]

 
  Peripheral and Central    March 23, March 24, June          3014512543
   Nervous System Drugs      dates to be announced
   Advisory Committee
------------------------------------------------------------------------
  Pharmaceutical Science    March 17                          3014512539
   and Clinical
   Pharmacology, Advisory
   Committee
------------------------------------------------------------------------
  Psychopharmacologic       To be announced                   3014512544
   Drugs Advisory
   Committee
------------------------------------------------------------------------
  Pulmonary Allergy Drugs   March 9, March 10, April          3014512545
   Advisory Committee        dates to be announced
------------------------------------------------------------------------
  Reproductive Health       May dates to be announced         3014512537
   Drugs, Advisory
   Committee
------------------------------------------------------------------------
CENTER FOR DEVICES AND RADIOLOGICAL HEALTH
------------------------------------------------------------------------
  Device Good               July 22, September 16             3014512398
   Manufacturing Practice
   Advisory Committee
------------------------------------------------------------------------
  Medical Devices Advisory Committee (Comprised of 18 Panels)
------------------------------------------------------------------------
  Anesthesiology and        April 30, June 23,                3014512624
   Respiratory Therapy       September 15, November
   Devices Panel             10
------------------------------------------------------------------------
  Circulatory System        February 25, May 27,              3014512625
   Devices Panel             September 23, December 8-
                             9
------------------------------------------------------------------------
  Clinical Chemistry and    March 17-18, June 16-17,          3014512514
   Clinical Toxicology       October 20-21
   Devices Panel
------------------------------------------------------------------------
  Dental Products Panel     March 23, April 13, May           3014512518
                             11, July 13, September
                             14
------------------------------------------------------------------------
  Ear, Nose, and Throat     February 24, May 19,              3014512522
   Devices Panel             August 25, November 3-4
------------------------------------------------------------------------
  Gastroenterology-Urology  March 11-12, June 17-18,          3014512523
   Devices Panel             September 9-10, December
                             2-3
------------------------------------------------------------------------
  General and Plastic       February 4-5, May 20-21,          3014512519
   Surgery Devices Panel     August 12-13, November 4-
                             5
------------------------------------------------------------------------
  General Hospital and      March 5, July 28-29,              3014512520
   Personal Use Devices      November 17-18
   Panel
------------------------------------------------------------------------
  Hematology and Pathology  January 21-22, April 22-          3014512515
   Devices Panel             23, July 8-9, October 21-
                             22
------------------------------------------------------------------------
  Immunology Devices Panel  April 26, September 15,           3014512516
                             December 6
------------------------------------------------------------------------
  Medical Devices Dispute   Meetings occur as needed          3014510232
   Resolution Panel
------------------------------------------------------------------------
  Microbiology Devices      March 19, September 23            3014512517
   Panel
------------------------------------------------------------------------
  Molecular and Clinical    April 15, October 5-6             3014510231
   Genetics Panel
------------------------------------------------------------------------
  Neurological Devices      March 11-12, May 13-4,            3014512513
   Panel                     July 8-9, October 7-8,
                             December 9-10
------------------------------------------------------------------------
  Obstetrics and            April 22-23, July 15-16,          3014512524
   Gynecology Devices        October 21-22, December
   Panel                     16-17
------------------------------------------------------------------------
  Ophthalmic Devices Panel  February 25-26, April 22-         3014512396
                             23, June 24-25, October
                             28-29, November 18-19
------------------------------------------------------------------------
  Orthopedic and            March 23, June 9-10,              3014512521
   Rehabilitation Devices    October 13-14, December
   Panel                     1-2
------------------------------------------------------------------------
  Radiological Devices      April 28, July 21,                3014512526
   Panel                     September 15, November
                             17
------------------------------------------------------------------------
  National Mammography      January 25                        3014512397
   Quality Assurance
   Advisory Committee
------------------------------------------------------------------------
  Technical Electronic      No meeting tentatively            3014512399
   Product Radiation         scheduled for 2010
   Safety Standards
   Committee
------------------------------------------------------------------------
CENTER FOR FOOD SAFETY AND APPLIED NUTRITION
------------------------------------------------------------------------
  Food Advisory Committee   May 20-21                         3014510564
------------------------------------------------------------------------
CENTER FOR VETERINARY MEDICINE
------------------------------------------------------------------------
  Veterinary Medicine       March 18-19                       3014512548
   Advisory Committee
------------------------------------------------------------------------
NATIONAL CENTER FOR TOXILOGICAL RESEARCH (NCTR)
------------------------------------------------------------------------

[[Page 69122]]

 
  Science Advisory Board    November 17-18                    3014512559
   to NCTR
------------------------------------------------------------------------
Center for Tobacco
------------------------------------------------------------------------
  Tobacco Products          March, May, July, and             8732110002
   Scientific Advisory       November dates to be
   Committee                 announced
------------------------------------------------------------------------


    Dated: December 24, 2009.
David Horowitz,
Assistant Commissioner for Policy.
[FR Doc. E9-30973 Filed 12-29-09; 8:45 am]
BILLING CODE 4160-01-S
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.